Lei Yuan, Yiting Bao. "Evaluation of the effectiveness and safety of disitamab vedotin for HER2-expressing advanced or recurrent gynecological cancers.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e17512